“…Furthermore, most studies characterizing clinical and/or histopathologic parameters were often insufficiently powered to reveal relevant prognostic indicators, owing in large part to the relative rarity of PVM (29). Nevertheless, many different clinical and histopathologic variables have been proffered to correlate with a higher risk of disease recurrence and survival in PVM, including higher age at diagnosis (4,(20)(21)(22)30), African American ethnicity (4,5,27,31), higher number of positive regional lymph nodes (4,22,24,29), central and/or multifocal vulvar involvement (21,22,26,30,32,33), increasing tumor thickness (3,9,20,21,(34)(35)(36)(37), ulceration (8,20,30,34,37), and dermal mitotic rate (8,20,24). Identification of the feature(s) among these that independently inform prognosis would greatly improve risk stratification and enable more personalized clinical management for patients with PVM, in particular, earlier and more aggressive intervention for those patients with highest risk disease.…”